Clinical Trials Directory

Trials / Terminated

TerminatedNCT02923037

Hatha Yoga in Breast Cancer Survivors

Feasibility and Preliminary Efficacy of Hatha Yoga in Breast Cancer Survivors: Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotional well-being (relaxation, meditation).

Detailed description

PRIMARY OBJECTIVES: I. To determine the feasibility of a modified yoga program for breast cancer survivors (BCS) with lymphedema. II. To identify and document required modifications for a safe and feasible practice. III. To obtain recruitment estimates and determine barriers to recruitment (acceptability). IV. To evaluate implementation fidelity (adherence and competence) and barriers to implementation fidelity. V. To establish safety. VI. To assess satisfaction. VII. To determine the preliminary efficacy of a modified yoga program for lymphedema in BCS, and associated physical and psychological symptoms/symptom burden, and overall health status. OUTLINE: Patients undergo an initial yoga evaluation for 60 minutes. Patients then undergo their first guided yoga practice session for 30-60 minutes and subsequent guided yoga sessions for 30-90 minutes. 3 times a week for 4 weeks, and twice a week for an additional 4 weeks. Patients are also encouraged to complete home yoga practice for 30 to 90 minutes every day for 8 weeks.

Conditions

Interventions

TypeNameDescription
PROCEDUREYogaComplete guided and home yoga sessions
OTHERtape measurement of armAncillary studies
OTHERQuality-of-Life AssessmentAncillary studies
OTHERldex measurement of arms

Timeline

Start date
2016-09-01
Primary completion
2018-11-01
Completion
2019-03-01
First posted
2016-10-04
Last updated
2019-03-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02923037. Inclusion in this directory is not an endorsement.